                         SEQUENCE LISTING

<110>  Atlantic Pharmaceutical (Holdings) Ltd
 
<120>  Use of composition

<130>  P54622WO/KVC

<150>  GB 1209895.0
<151>  2012-06-01

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Oligonucleotide

<400>  1
gcccaagctg gcatccgtca                                                   20


<210>  2
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Oligonucleotide

<400>  2
cctgacggat gccagcttgg                                                   20


<210>  3
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Oligonucleotide

<400>  3
cccaagctgg catccgtca                                                    19


<210>  4
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Oligonucleotide

<400>  4
gcccaagctg gcatccgtc                                                    19


<210>  5
<211>  13
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Oligonucleotide

<400>  5
gcccaagctg gca                                                          13


